Crossmark

Updating the Brazilian clinical practice guidelines for sickle cell disease: Recommendations and development process

Crossref DOI link: https://doi.org/10.1016/j.htct.2025.103964

Published Print: 2025-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gargano, Ludmila Peres https://orcid.org/0000-0002-0666-7776
Fachi, Mariana Millan https://orcid.org/0000-0001-5918-4738
Oliveira, Layssa Andrade https://orcid.org/0000-0001-9036-3056
Lobo, Clarisse https://orcid.org/0009-0003-8954-1902
Melnikoff, Katharina Nelly Tobos https://orcid.org/0009-0006-3983-2527
Soriano, Selma https://orcid.org/0009-0007-2384-5873
Maior, Marta da Cunha Lobo Souto https://orcid.org/0000-0001-9457-9946
Kron-Rodrigues, Meline Rossetto https://orcid.org/0000-0003-2174-268X
Gomes, Dalila Fernandes https://orcid.org/0000-0002-2864-0806
Oliveira Junior, Haliton Alves https://orcid.org/0000-0002-0289-4947
Lucchetta, Rosa Camila https://orcid.org/0000-0002-4004-1320
Funding

Funding for this research was provided by:

Ministry of Health
License Information

Text and Data Mining valid from 2025-10-01

Text and Data Mining valid from 2025-10-01

Version of Record valid from 2025-07-30
More Information

This article is maintained by: Elsevier

Article Title: Updating the Brazilian clinical practice guidelines for sickle cell disease: Recommendations and development process

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2025.103964

Content Type: article

Copyright: © 2025 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.